The Every Company Closes $175M Series C Funding Round

The Every Company
Arturo Elizondo, CEO and founder of The EVERY Company in EVERY’s corporate kitchen, South San Francisco, California (Photo: Business Wire)

The Every Company, a San Francisco, CA-based precision fermentation platform accelerating a global transition to animal-free protein, closed $175m in Series C financing.

The round, which brings total funding to $233m, was co-led by new investor McWin, and existing investor Rage Capital. Other new and existing investors joined the round including Temasek, Grosvenor’s Wheatsheaf Group, and TO Ventures. Prosus Ventures also contributed to the funding.

The company will use the capital:

  • to scale production,
  • commercialize a pipeline of animal-free protein products nationwide,
  • expand into a broad array of new food applications, and
  • grow its protein production platform by mining the egg proteome for novel, hyper-functional proteins.

Led by Arturo Elizondo, CEO and founder, The Every Company is the market leader in engineering, manufacturing and formulating animal-free animal proteins for the global food and beverage industry. Last year, the company launched an animal-free pepsin with Fortune 500 ingredients company, Ingredion. Most recently, it launched an animal-free egg protein. In November, EVERY™ made its retail debut by announcing a limited time partnership with leading national cold-pressed juice brand Pressed to serve a nature-equivalent animal-free protein smoothie directly to consumers.

Proteins by EVERY™ are distributed globally by Ingredion, a Fortune 500 ingredients solutions company.